These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1368 related items for PubMed ID: 17684964

  • 1. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA, Storozhakov GI, Gendlin GE, Badaeva SV, Zhidkova DA, Kim IG, Borisovskaia SV, Loss KE, Fedorova ND.
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [Abstract] [Full Text] [Related]

  • 2. [Left ventricular myocardial hypertrophy after transplantation of the kidney: risk factors and possible regress].
    Tomilina NA, Gendlin GE, Zhidkova DA, Tronina OA, Fedorova ND.
    Ter Arkh; 2009; 81(8):42-8. PubMed ID: 19799199
    [Abstract] [Full Text] [Related]

  • 3. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease].
    Rudenko TE, Kutyrina IM, Shvetsov MIu.
    Ter Arkh; 2012; 84(6):21-6. PubMed ID: 22997913
    [Abstract] [Full Text] [Related]

  • 4. Correlation of anemia, secondary hyperparathyroidism with left ventricular hypertrophy in Chronic Kidney Disease patients.
    Datta S, Abraham G, Mathew M, Somasundaram H, Muralidharan TR, Moorthy A, Sathyasekaran, Leslie N.
    J Assoc Physicians India; 2006 Sep; 54():699-703. PubMed ID: 17212016
    [Abstract] [Full Text] [Related]

  • 5. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
    Tsioufis C, Vezali E, Tsiachris D, Dimitriadis K, Taxiarchou E, Chatzis D, Thomopoulos C, Syrseloudis D, Stefanadi E, Mihas C, Katsi V, Papademetriou V, Stefanadis C.
    J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
    [Abstract] [Full Text] [Related]

  • 6. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
    [Abstract] [Full Text] [Related]

  • 7. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M, Ohashi K, Akiyama H, Sakamaki H, Morito T, Tsuchiya K, Nitta K.
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [Abstract] [Full Text] [Related]

  • 8. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
    Muiesan ML, Salvetti M, Rizzoni D, Monteduro C, Castellano M, Agabiti-Rosei E.
    J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
    [Abstract] [Full Text] [Related]

  • 9. Effects of successful renal transplantation on left ventricular mass.
    Montanaro D, Gropuzzo M, Tulissi P, Vallone C, Boscutti G, Mioni R, Risaliti A, Baccarani U, Adani GL, Sainz M, Lorenzin D, Bresadola F, Mioni G.
    Transplant Proc; 2005 Dec; 37(6):2485-7. PubMed ID: 16182718
    [Abstract] [Full Text] [Related]

  • 10. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
    Chitalia N, Raja RB, Bhandara T, Agrawal P, Kaski JC, Jha V, Banerjee D.
    J Nephrol; 2010 Dec; 23(1):77-84. PubMed ID: 20091490
    [Abstract] [Full Text] [Related]

  • 11. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 12. [Left ventricular hypertrophy in chronic kidney disease].
    Paoletti E, Cannella G.
    G Ital Nefrol; 2006 May; 23(6):560-8. PubMed ID: 17173262
    [Abstract] [Full Text] [Related]

  • 13. Left ventricular hypertrophy in patients with chronic kidney disease under conservative treatment.
    Bregman R, Lemos C, Pecoits Filho R, Abensur H, Draibe S, Bastos MG, Canziani ME.
    J Bras Nefrol; 2010 Mar; 32(1):83-8. PubMed ID: 21448524
    [Abstract] [Full Text] [Related]

  • 14. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Mar; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

  • 15. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M, Kawar B, El Nahas AM.
    Nephron Clin Pract; 2009 Mar; 113(1):c16-23. PubMed ID: 19590231
    [Abstract] [Full Text] [Related]

  • 16. Time-dependent changes in cardiac growth after kidney transplantation: the impact of pre-dialysis ventricular mass.
    Hernández D, González A, Rufino M, Laynez I, de la Rosa A, Porrini E, Lacalzada J, Barragán A, Lorenzo V, Torres A.
    Nephrol Dial Transplant; 2007 Sep; 22(9):2678-85. PubMed ID: 17510095
    [Abstract] [Full Text] [Related]

  • 17. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
    Marcén R, del Castillo D, Capdevila L, Fernandez-Fresnedo G, Rodrigo E, Cantarell C, Fernández-Rodriguez A, López-Oliva MO, Camps J, Aljama P, Ortuño J, Arias M.
    Transplantation; 2009 May 15; 87(9):1340-6. PubMed ID: 19424034
    [Abstract] [Full Text] [Related]

  • 18. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme.
    Soares CM, Diniz JS, Lima EM, Oliveira GR, Canhestro MR, Colosimo EA, Simoes e Silva AC, Oliveira EA.
    Nephrol Dial Transplant; 2009 Mar 15; 24(3):848-55. PubMed ID: 18840891
    [Abstract] [Full Text] [Related]

  • 19. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Wang MC, Tsai WC, Chen JY, Huang JJ.
    Am J Kidney Dis; 2005 Mar 15; 45(3):494-501. PubMed ID: 15754271
    [Abstract] [Full Text] [Related]

  • 20. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun 15; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 69.